- Home
- JEF vs ELAN Comparison
JEF vs ELAN Comparison
Compare JEF & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JEF
- ELAN
- Stock Information
- Founded
- JEF 1968
- ELAN 1954
- Country
- JEF United States
- ELAN United States
- Employees
- JEF N/A
- ELAN N/A
- Industry
- JEF Investment Bankers/Brokers/Service
- ELAN Biotechnology: Pharmaceutical Preparations
- Sector
- JEF Finance
- ELAN Health Care
- Exchange
- JEF Nasdaq
- ELAN Nasdaq
- Market Cap
- JEF 10.5B
- ELAN 10.3B
- IPO Year
- JEF N/A
- ELAN 2018
- Fundamental
- Price
- JEF $56.91
- ELAN $22.14
- Analyst Decision
- JEF Buy
- ELAN Buy
- Analyst Count
- JEF 4
- ELAN 8
- Target Price
- JEF $71.00
- ELAN $20.00
- AVG Volume (30 Days)
- JEF 4.0M
- ELAN 4.9M
- Earning Date
- JEF 09-29-2025
- ELAN 11-05-2025
- Dividend Yield
- JEF 2.82%
- ELAN N/A
- EPS Growth
- JEF 25.06
- ELAN N/A
- EPS
- JEF 2.92
- ELAN 0.88
- Revenue
- JEF $7,231,501,000.00
- ELAN $4,484,000,000.00
- Revenue This Year
- JEF $5.71
- ELAN $5.77
- Revenue Next Year
- JEF $9.93
- ELAN $4.96
- P/E Ratio
- JEF $19.62
- ELAN $25.19
- Revenue Growth
- JEF 15.68
- ELAN N/A
- 52 Week Low
- JEF $39.28
- ELAN $8.02
- 52 Week High
- JEF $82.68
- ELAN $22.26
- Technical
- Relative Strength Index (RSI)
- JEF 48.04
- ELAN 74.55
- Support Level
- JEF $48.51
- ELAN $21.19
- Resistance Level
- JEF $55.78
- ELAN $21.82
- Average True Range (ATR)
- JEF 2.50
- ELAN 0.63
- MACD
- JEF 0.23
- ELAN 0.06
- Stochastic Oscillator
- JEF 62.50
- ELAN 95.71
About JEF Jefferies Financial Group Inc.
Jefferies is a full-service investment banking and capital markets firm that was founded in 1962. After nearly 30 years of focusing on institutional trading services, it entered the investment banking industry in the early 1990s, which ultimately grew into the core business. In 2013, Jefferies merged with Leucadia, a manufacturing-focused holding company. Since merging, Jefferies became the bedrock of the business as the bulk of the legacy portfolio was sold off and the parent company was renamed to match the subsidiary. Within the investment banking landscape, Jefferies predominately serves the North American middle market and has captured considerable market share over the past decade.
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.